Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance

被引:92
作者
Burgess, DS
机构
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA
[2] Univ Texas, Austin, TX 78712 USA
关键词
antibiotic pharmacodynamics; antibiotic pharmacokinetics; concentration-dependent drugs; concentration-independent drugs; continuous infusion; postantibiotic effect;
D O I
10.1378/chest.115.suppl_1.19S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Pharmacodynamic properties can be used to divide antibiotics into two major classes based on their mechanism of bactericidal action: (1) concentration-dependent drugs, such as aminoglycosides and fluoroquinolones, and (2) concentration-independent drugs, including the beta-lactams, Antibiotics also differ in the postantibiotic effect (PAE) that they exert. In general, concentration-dependent drugs have a more prolonged PAE than concentration-independent drugs, particularly against Gram-negative pathogens. Pharmacodynamic classifications have important implications for the planning of drug regimens. For concentration-dependent drugs, peak concentration to minimal inhibitory concentration (MIC) ratios of approximately 10 are associated with clinical success. Therefore, high drug levels should be the goal of therapy. This is best achieved by high doses taken once daily. This approach, however, is not feasible for the fluoroquinolones owing to dose-limiting CNS toxicity. Concentration-independent agents are most effective when the duration of serum concentrations is higher than the pathogen's MIC (time > MIC) for a significant proportion of the dosing interval, Frequent dosing or continuous infusions can increase the time > MIC. Concentrations of antibiotics that are sublethal can permit the emergence of resistant pathogens. Optimization of antibiotic regimens on the basis of pharmacodynamic principles could thus significantly diminish the emergence of antibiotic resistance.
引用
收藏
页码:19S / 23S
页数:5
相关论文
共 18 条
[1]   Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections [J].
Benko, AS ;
Cappelletty, DM ;
Kruse, JA ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :691-695
[2]   Pharmacokinetics and pharmacodynamics of antibiotics in otitis media [J].
Craig, WA ;
Andes, D .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) :255-259
[3]   INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J].
CRAIG, WA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) :89-96
[4]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[5]   POSTANTIBIOTIC EFFECTS IN EXPERIMENTAL-INFECTION MODELS - RELATIONSHIP TO INVITRO PHENOMENA AND TO TREATMENT OF INFECTIONS IN MAN [J].
CRAIG, WA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :149-158
[6]   PHARMACODYNAMICS OF AMIKACIN INVITRO AND IN MOUSE THIGH AND LUNG INFECTIONS [J].
CRAIG, WA ;
REDINGTON, J ;
EBERT, SC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 :29-40
[7]   Alteration of postantibiotic effect during one dosing interval of tobramycin, simulated in an in vitro pharmacokinetic model [J].
denHollander, JG ;
Mouton, JW ;
vanGoor, MLPJ ;
Vleggaar, FP ;
Verbrugh, HA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :784-786
[8]   PHARMACODYNAMICS OF A FLUOROQUINOLONE ANTIMICROBIAL AGENT IN A NEUTROPENIC RAT MODEL OF PSEUDOMONAS SEPSIS [J].
DRUSANO, GL ;
JOHNSON, DE ;
ROSEN, M ;
STANDIFORD, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :483-490
[9]  
FANTIN B, 1990, J ANTIMICROB CHEMOTH, V27, P829
[10]   In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli [J].
Fass, RJ ;
Barnishan, J ;
Solomon, MC ;
Ayers, LW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) :1412-1418